During the past decade, Yangpu District Central Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yangpu District Central Hospital" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Changhai Hospital" with 1 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yangpu District Central Hospital" #1 collaborator was "Yangpu District Central Hospital Affiliated to Tongji University" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ruijin Hospital" with 1 trials as a collaborator, "Shanghai 6th People's Hospital" with 1 trials as a collaborator and "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Yangpu District Central Hospital" are "Atrial Fibrillation" (1 trials), "Breast Neoplasms" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Peripheral Neuropathic Pain" (1 trials) and "Esophageal Diseases" (1 trials). Many other conditions were trialed in "Yangpu District Central Hospital" in a lesser frequency.

Most popular intervention types in "Yangpu District Central Hospital" are "Drug" (4 trials), "Behavioral" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aromasin (exemestane)" (1 trials), "Cognitive Training" (1 trials), "Edoxaban" (1 trials), "Mirogabalin" (1 trials) and "Non-anticoagulant medical therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yangpu District Central Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yangpu District Central Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Yangpu District Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yangpu District Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".